Person: Chief Scientific Officer

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Regeneron, Sanofi arthritis drug fails Covid-19 study

Biotech company Regeneron said its rheumatoid arthritis drug Kevzara failed to meet the main goals of a US study testing it in the most critically ill Covid-19 patients

Fri, 03 Jul, 2020

Irish company awarded €2.5m to battle Covid-19

An Irish biotechnology company has been awarded €2.5m in European funding for its Covid-19 response technology.

Tue, 09 Jun, 2020

Regeneron says Covid treatment may be ready this autumn

Biotech company Regeneron is to increase the number of medicines manufactured at its Limerick facility in order to ramp up production of their COVID-19 drug treatment in the US.

Thu, 07 May, 2020

Foundation calls for action on stem-cell legislation

The Irish Stem Cell Foundation has warned that current restrictions on research in Ireland are preventing inward investment in the bio-tech sector.

Mon, 19 Mar, 2012

Elan to sponsor Alzheimer's conference

ISEQ-listed biotechnology company Elan announced today that it is to be the main sponsor of the ninth International Conference on Alzheimer’s Disease and Related Disorders.

Mon, 17 May, 2004

Person: Chief Scientific Officer

Regeneron, Sanofi arthritis drug fails Covid-19 study

Irish company awarded €2.5m to battle Covid-19

Regeneron says Covid treatment may be ready this autumn

Foundation calls for action on stem-cell legislation

Elan to sponsor Alzheimer's conference

Latest

Mick Clifford

Person: Chief Scientific Officer

Regeneron, Sanofi arthritis drug fails Covid-19 study

Irish company awarded €2.5m to battle Covid-19

Regeneron says Covid treatment may be ready this autumn

Foundation calls for action on stem-cell legislation

Elan to sponsor Alzheimer's conference

Latest

Mick Clifford

Most Read